Read More Pharma Industry News Omeros stock skyrockets as narsoplimab improves survival in pivotal TA-TMA trial Omeros Corporation, a Seattle-based biopharmaceutical company, is making waves after releasing results from its pivotal clinical trial for… byPallavi MadhirajuDecember 19, 2024